BiomarkersHumans118 participants2 yearsCohort study

Cerebrospinal Fluid Over Plasma Links Analytes to Cognitive Decline in Older Adults at Risk for Alzheimer's Disease

Figure 1. A framework for comparing dynamic analyte levels between baseline and 2‐year follow‐up in cognitive decline.
Open the figure at full size
Figure 1. A framework for comparing dynamic analyte levels between baseline and 2‐year follow‐up in cognitive decline.A framework for comparing dynamic analyte levels between baseline and 2‐year follow‐up in cognitive decline.Pillai et al.

Annals of Clinical and Translational Neurology

The paper

Pillai JA, Zhu A, Ma C et al.

Annals of Clinical and Translational Neurology · 17 Sep 2026

doi.org/10.1002/acn3.70532PubMed 42754972